| Metric | შპს ნიუ ფარმა | შპს ნიუ ფარმა NEW PHARMA |
|---|---|---|
| Growth | ||
| Revenue | ₾21.9m₾18.3m | ₾883₾4.1m |
| Revenue growth | 19.6% | -100.0% |
| Profitability | ||
| EBITDA | ₾3.5m₾5.3m | -₾262k-₾476k |
| EBITDA margin | 15.8%29.2% | -29687.2%-11.6% |
| Net profit | ₾2.1m₾4.6m | -₾258k-₾726k |
| Net margin | 9.7%24.9% | -29249.2%-17.7% |
| Balance sheet | ||
| Total assets | ₾10.9m₾13.2m | ₾83k₾1.4m |
| Total equity | ₾5.9m₾5.5m | -₾780k-₾522k |
| ROE | 36.1%82.8% | — |